Thank you, Mr. Chair.
Dr. Nemer, thank you very much. It's wonderful to see you again. Thank you for coming back to our committee. I know that you appeared once before as a witness. Let me thank you again for your contributions to our foundational first study and for the insight you shared with us at the time, when we studied graduate scholarships in June.
Personally, I think having a chief science advisor for our country is a big deal. Canadians should know more about the role and the work you've done and are doing and should be able to see and feel that scientific inquiry is valued and put to use in our country and in our policy-making.
For the benefit of those watching us at home throughout the country, your current post dates back to 2017, but you've come to this post with a long record of contributions to science in Canada. I know that you've trained more than 100 graduate and post-graduate students in your career, and have mentored and counselled many more. You're a leader in the field of molecular cardiology and have helped to make great strides in heart health with your research. You've also published over 200 academic publications and have made significant contributions to Canada's response to the pandemic.
This is work that not only keeps people safe and supports their health, but gives hope: hope that science can be put to use to better our world. In fact, I think where we met you in the last couple of years was at the Science Meets Parliament event. The number of students who have been coming here and have been introduced to the parliamentary work we do is so crucial in their fields, but also in our fields as parliamentarians, so that we can better connect.
I want to take this opportunity so that it does not go past me to say that it's very nice for me personally to see a fellow Lebanese Canadian woman in your position making a big difference in Canada. Thank you.
Your work as chief science advisor is broad. Your office provides advice to government on improving support for quality research and enhancing the science advisory function within government, including processes for science-informed decisions. I felt it was important to put that on the record, because it really makes a big difference.
In the age of disinformation, science has become political. Can you talk to the committee about the impact of disinformation on science? How can we combat it and what can your office do to safeguard science? What is the role that your office can play in protecting science in Canada? It's a pretty broad question, but I'm going to leave the opportunity for you to enlighten us on that.